March 22, 2024
The second sentencing of a former Aegerion Pharmaceuticals Inc. salesman did not add a day in prison to the roughly seven months he served before the First Circuit wiped away his initial conviction on charges he schemed to fraudulently sell the company's cholesterol treatment.
March 14, 2024
A pharmaceutical sales representative who gloated about being a "puppet master" for false insurance claims for Aegerion's cholesterol drug should serve 20 months in prison, the U.S. government has told a Boston federal judge.
November 21, 2023
A former Aegerion Pharmaceuticals sales representative pled guilty Tuesday in Boston federal court to fraudulently selling the company's cholesterol treatment, ending a nearly 6-year-old case that saw an initial conviction vacated due to a faulty jury charge.
November 13, 2023
A former Aegerion Pharmaceuticals sales representative will plead guilty to his involvement in a scheme to fraudulently sell the company's cholesterol treatment, forgoing a second trial and ending a long-running case that saw his first conviction wiped out due to faulty jury instructions.
September 14, 2023
A former Aegerion Pharmaceuticals sales representative cannot wield a recent U.S. Supreme Court ruling narrowing prosecutors' use of the identity theft statute to escape charges tied to an alleged scheme to fraudulently sell the company's cholesterol treatment, a Boston federal judge ruled Thursday.
August 10, 2023
Federal prosecutors on Wednesday argued that a recent U.S. Supreme Court ruling does not let a former Aegerion Pharmaceuticals sales representative off the hook on identity theft charges tied to his alleged scheme to fraudulently hawk the company's expensive cholesterol treatment.
July 27, 2023
A former Aegerion Pharmaceuticals sales representative who faces a possible second trial on fraud and identity theft charges following a faulty jury instruction is arguing a recent U.S. Supreme Court ruling invalidates part of the government's case.
March 23, 2023
Federal prosecutors told a Boston federal judge that a simple date correction in an updated indictment charging a former Aegerion Pharmaceuticals sales representative with fraud and identity theft isn't nearly enough to warrant tossing the counts from the case.
January 10, 2023
Federal prosecutors are in early talks with a former Aegerion Pharmaceuticals Inc. salesman to resolve allegations that he ran a drug fraud scheme, after the First Circuit tossed his conviction due to an improper jury verdict slip.
April 19, 2022
A former Aegerion Pharmaceuticals Inc. salesman convicted of fraud should repay $1.6 million to three insurers he duped into paying for the company's cholesterol drug, prosecutors told a Boston federal judge on Tuesday.